ClinicalTrials.gg
RecruitingNCT06893419GET-HEALTH-IUpdated Sep 8, 2025

Geriatric Telemanagement of HEALTH Conditions in Nursing Home Residents Recently Discharged From the Hospital- GET HEALTH-I

An interventional study of Geriatric telemanagement in Older Hospitalized Patients, sponsored by Istituto Nazionale di Ricovero e Cura per Anziani. Recruiting at 1 site in Italy. Open to participants aged 70 Years and older. Per ClinicalTrials.gov, last updated 2025-09-08.

Sponsored by Istituto Nazionale di Ricovero e Cura per Anziani · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Primary completion was expected by Mar 2026, 7 months ago, but the record still lists the study as recruiting.
  • Registered 1 year 1 month after the study started (first participant enrolled Feb 2024, registered Mar 2025).
  • Started Feb 2024; still recruiting 2 years 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
102
Allocation
Not applicable
Ages
70 Years and older
Sex
All
01

Study summary

Get-HEALTH-I study is a retrospective prospective interventional study to evaluate the impact of a geriatric telemanagement program on cost-effectiveness and clinical outcomes in nursing home residents post-hospital discharge.

Read the detailed description

The GET HEALTH-I is a before and after study, consisting of both a retrospective and prospective component. The retrospective component of the study includes nursing home residents in the Marche region (Italy) who are readmitted to the nursing home after a hospital discharge, before the implementation of geriatric telemanagement. The prospective component, includes nursing home residents who are readmitted to the nursing home after a hospital discharge and are managed with the geriatric telemedicine intervention in addition to usual care. The primary objective of the study is to develop a geriatric co-management governance model using telemedicine for elderly patients with multimorbidity discharged from the hospital to nursing homes.The model will integrate geriatric specialists with nursing home staff and general practitioners.

A secondary objective of the study is to measure the performance of the model in terms of effectiveness and cost-effectiveness. In particular, an evaluation will be conducted on the effects of implementing the geriatric telemanagement governance model on the risk of hospitalization, geriatric syndromes (falls, delirium, pressure ulcers), number of medications, and inappropriate prescriptions. Adherence to the intervention by GPs and nursing home staff, satisfaction and perception of utility, costs, healthcare resource utilization, and cost-effectiveness will be evaluated.

02

Conditions studied

  • Older Hospitalized Patients

Keywords

  • older patients
  • comprehensive geriatric assessment
  • nursing home
  • health technology assessment
  • telemanagement
03

In context

Lead sponsor

Istituto Nazionale di Ricovero e Cura per Anziani is the lead sponsor of 42 studies on the registry; 21 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
70 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Nursing home residents discharged from the hospital within one week of admission to the nursing home

Exclusion criteria

Exclusion Criteria:

  • Residents admitted for a short-term stay
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
102 participants (estimated)

Study arms

  • Experimental
    Nursing home residents

    A geriatric comprehensive assessment (CGA) will be conducted in nursing home residents using the data collection form by a multidisciplinary team led by the geriatrician, together with the family physician and the nursing home staff. The geriatrician will review the diagnoses, treatments, and results of the CGA. The patient will be interviewed and examined by the team, and then a multidisciplinary conference will be organized.

    Other: Geriatric telemanagement

Interventions

  • OtherGeriatric telemanagement

    The geriatrician will coordinate, through a telemedicine consultation, a team consisting of the general practitioner and the nursing home staff. The geriatrician will review the diagnoses, treatments, and results of the comprehensive geriatric assessment performed by the nursing home staff. Subsequently, the entire team will conduct a multidisciplinary conference.

06

What researchers measure

Primary outcomes

  1. reduction in hospitalization rate

    A minimum 15% reduction in the hospitalization rate will define the efficacy of the geriatric telemedicine consultation intervention

    Time frame: After 6 months from baseline

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Feb 2024 (actual). Primary completion is estimated for Mar 2026, 25 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 18, 2025
First posted
Mar 25, 2025
StartActual
Feb 4, 2024
Primary completionEst.
Mar 31, 2026
CompletionEst.
Mar 31, 2026
Last update
Sep 8, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 8, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06893419
Lead sponsor
Istituto Nazionale di Ricovero e Cura per Anziani
Collaborators
Ministry of Health, Italy
Responsible party
Sponsor
First posted
Mar 25, 2025
Start date
Feb 4, 2024
Primary completion
Mar 31, 2026 (estimated)
Completion
Mar 31, 2026 (estimated)
Last update
Sep 8, 2025

Study contacts

Anna Rita Bonfigli, PhD
Contact
a.bonfigli@inrca.it
0718003719
Antonio Cherubini, MD
principal investigator · IRCCS INRCA, Ancona, Italy

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion